Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: Effect on vascular reactivity and stiffness

Chemico-Biological Interactions

Volumn 213, Issue 1, 2014, Pages 28-36

  Hassan, Noura Ahmed ^a   El Bassossy, Hany M ^a,b   Mahmoud, Mona Fouad ^a   Fahmy, Ahmed ^a  

^a Zagazig University   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Aorta; Atherosclerosis; Caffeic acid phenethyl ester; Diabetes; Vascular reactivity

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CAFFEIC ACID PHENETHYL ESTER; COLLAGEN; FRUCTOSE; GLUCOSE; HEME OXYGENASE 1; INSULIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN RESISTANCE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE;

AORTA; ATHEROSCLEROSIS; CAFFEIC ACID PHENETHYL ESTER; DIABETES; VASCULAR REACTIVITY;

ANIMALS; AORTA; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY WEIGHT; CAFFEIC ACIDS; DIABETES COMPLICATIONS; IMMUNOHISTOCHEMISTRY; INSULIN; LIPOXYGENASE INHIBITORS; MALE; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR; VASCULAR STIFFNESS; VASOCONSTRICTION;

EID: 84896738346     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.01.019     Document Type: Article

References (73)

1. B.V. Howard, B.L. Rodriguez, P.H. Bennett, M.I. Harris, R. Hamman, L.H. Kuller, T.A. Pearson, and J. Wylie-Rosett Prevention conference VI: diabetes and cardiovascular disease: writing group I: epidemiology Circulation 105 2002 e132 e137
2. C.C. Cowie, K.F. Rust, D.D. Byrd-Holt, M.S. Eberhardt, K.M. Flegal, M.M. Engelgau, S.H. Saydah, D.E. Williams, L.S. Geiss, and E.W. Gregg Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population Diabetes Care 29 2006 1263 1268
3. R. Carmena Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance Am. Heart J. 150 2005 859 870 (Pubitemid 41607755)
4. M. Jean, M. Alameh, D. De Jesus, M. Thibault, M. Lavertu, V. Darras, M. Nelea, M.D. Buschmann, and A. Merzouki Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes Eur. J. Pharm. Sci. 45 2012 138 149
5. J.Y. Park, S.W. Ha, and G.L. King The role of protein kinase C activation in the pathogenesis of diabetic vascular complications Perit. Dial. Int. 19 1999 S222 S227
6. S.M. Grundy, B. Howard, S. Smith Jr., R. Eckel, R. Redberg, and R.O. Bonow Prevention conference VI: diabetes and cardiovascular disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American heart association Circulation 105 2002 2231 2239 (Pubitemid 34517172)
7. R.H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barrett, G. King, M. Lopes-Virella, J. Reusch, N. Ruderman, G. Steiner, and H. Vlassara Prevention conference VI: diabetes and cardiovascular disease: writing group II: pathogenesis of atherosclerosis in diabetes Circulation 105 2002 e138 e143
8. M. Kaaman, M. Ryden, T. Axelsson, E. Nordstrom, A. Sicard, A. Bouloumie, D. Langin, P. Arner, and I. Dahlman ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance Int. J. Obes. (Lond) 30 2006 447 452
9. M. Back, A. Sultan, O. Ovchinnikova, and G.K. Hansson 5-lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation Circ. Res. 100 2007 946 949 (Pubitemid 46598919)
10. O.K. Mirzoeva, and P.C. Calder The effect of propolis and its components on eicosanoid production during the inflammatory response Prostaglandins Leukot. Essent. Fatty Acids 55 1996 441 449 (Pubitemid 27014134)
11. F. Cipollone, A. Mezzetti, M.L. Fazia, C. Cuccurullo, A. Iezzi, S. Ucchino, F. Spigonardo, M. Bucci, F. Cuccurullo, S.M. Prescott, and D.M. Stafforini Association between 5-lipoxygenase expression and plaque instability in humans Arterioscler. Thromb. Vasc. Biol. 25 2005 1665 1670 (Pubitemid 41098938)
12. Y.J. Zhou, J.H. Wang, L. Li, H.W. Yang, L. De Wen, and Q.C. He Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability Biochem. Biophys. Res. Commun. 363 2007 30 36 (Pubitemid 47430091)
13. A.A. Albukhari, H.M. Gashlan, H.A. El-Beshbishy, A.A. Nagy, and A.B. Abdel-Naim Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats Food Chem. Toxicol. 47 2009 1689 1695
14. C.V. Fontanilla, X. Wei, L. Zhao, B. Johnstone, R.M. Pascuzzi, M.R. Farlow, and Y. Du Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis Neuroscience 205 2012 185 193
15. Y. Feng, Y.W. Lu, P.H. Xu, Y. Long, W.M. Wu, W. Li, and R. Wang Caffeic acid phenethyl ester extends and its related compounds limit the functional alterations of the isolated mouse brain and liver mitochondria submitted to in vitro anoxial-reoxygenation: relationship to their antioxidant activities Biochim. Biophys. Acta (BBA) Gen. Subj. 1780 2008 659 672
16. Y. Yao-Hsu Caffeic acid phenethyl ester possessing various immunomodulatory effects is a potentially effective therapy for asthma Pediatr. Neonatol. 52 2011 307 308
17. H.K. Na, M.R. Wilson, K.S. Kang, C.C. Chang, D. Grunberger, and J.E. Trosko Restoration of gap junctional intercellular communication by caffeic acid phenethyl ester (CAPE) in a ras-transformed rat liver epithelial cell line Cancer Lett. 157 2000 31 38 (Pubitemid 30421228)
18. K. Hishikawa, T. Nakaki, and T. Fujita Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 25 2005 442 446 (Pubitemid 40189171)
19. E. Fadillioglu, C. Gursul, and M. Iraz Effects of caffeic acid phenethyl ester on thioacetamide-induced hepatic encephalopathy in rats Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 1440 1445
20. Y. Lee, D.H. Shin, J.H. Kim, S. Hong, D. Choi, Y.J. Kim, M.K. Kwak, and Y. Jung Caffeic acid phenethyl ester-mediated Nrf2 activation and I kappa B kinase inhibition are involved in NF kappa B inhibitory effect: structural analysis for NFkappaB inhibition Eur. J. Pharmacol. 43 1 2010 21 28
21. H.M. El-Bassossy, A. Fahmy, and R. El-Fawal Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production Vascul. Pharmacol. 57 2012 194 200
22. H.M. El-Bassossy, A. Fahmy, and D. Badawy Cinnamaldehyde protects from the hypertension associated with diabetes Food Chem. Toxicol. 49 2011 3007 3012
23. R. Sampathkumar, M. Balasubramanyam, M. Rema, C. Premanand, and V. Mohan A novel advanced glycation index and its association with diabetes and microangiopathy Metabolism 54 2005 1002 1007 (Pubitemid 41033099)
24. K. Szocs, B. Lassegue, D. Sorescu, L.L. Hilenski, L. Valppu, T.L. Couse, J.N. Wilcox, M.T. Quinn, J.D. Lambeth, and K.K. Griendling Upregulation of nox-based NAD(P)H oxidases in restenosis after carotid injury Arterioscler. Thromb. Vasc. Biol. 22 2002 21 27 (Pubitemid 34076227)
25. N. Hu, S. Xie, L. Liu, X. Wang, X. Pan, G. Chen, L. Zhang, H. Liu, X. Liu, X. Liu, L. Xie, and G. Wang Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats Drug Metab. Dispos. 39 2011 419 425
26. S. Dai, and J.H. McNeill Fructose-induced hypertension in rats is concentration- and duration-dependent J. Pharmacol. Toxicol. Methods 33 1995 101 107
27. J.J. Li, and J.L. Chen Inflammation may be a bridge connecting hypertension and atherosclerosis Med. Hypotheses 64 2005 925 929
28. M.F. O'Rourke, and W.W. Nichols Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension Hypertension 45 2005 652 658 (Pubitemid 40418361)
29. I. Wakabayashi, and H. Masuda Association of pulse pressure with fibrinolysis in patients with type 2 diabetes Thromb. Res. 121 2007 95 102 (Pubitemid 350025998)
30. H. Mollaoglu, A. Gokcimen, F. Ozguner, F. Oktem, A. Koyu, A. Kocak, H. Demirin, O. Gokalp, and E. Cicek Caffeic acid phenethyl ester prevents cadmium-induced cardiac impairment in rat Toxicology 227 2006 15 20 (Pubitemid 44404226)
31. Y.J. Ho, W.P. Chen, T.C. Chi, C.C. Chang Chien, A.S. Lee, H.L. Chiu, Y.H. Kuo, and M.J. Su Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in streptozotocin-induced diabetic rats Cardiovasc. Diabetol. 12 2013 1475 2840
32. S.M. Mansour, A.K. Bahgat, A.S. El-Khatib, and M.T. Khayyal Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K, 1C hypertensive rats: role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction Phytomedicine 18 2011 641 647
33. K.M. MacLeod The effect of insulin treatment on changes in vascular reactivity in chronic, experimental diabetes Diabetes 34 1985 1160 1167
34. Y. Kinoshita, M. Saito, I. Satoh, K. Shomori, H. Suzuki, M. Yamada, T. Kono, and K. Satoh General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta Life Sci. 78 2006 1508 1514 (Pubitemid 43233820)
35. X. Wang, S. Stavchansky, B. Zhao, J.A. Bynum, S.M. Kerwin, and P.D. Bowman Cytoprotection of human endothelial cells from menadione cytotoxicity by caffeic acid phenethyl ester: the role of heme oxygenase-1 Eur. J. Pharmacol. 591 2008 28 35
36. X. Wang, S. Stavchansky, S.M. Kerwin, and P.D. Bowman Structure-activity relationships in the cytoprotective effect of caffeic acid phenethyl ester (CAPE) and fluorinated derivatives: effects on heme oxygenase-1 induction and antioxidant activities Eur. J. Pharmacol. 635 2010 16 22
37. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol. Rev. 60 2008 79 127 (Pubitemid 351439218)
38. J.E. Clark, R. Foresti, C.J. Green, and R. Motterlini Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress Biochem. J. 348 Pt 3 2000 615 619 (Pubitemid 30410252)
39. K. Omata, N.G. Abraham, and M.L. Schwartzman Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR Am. J. Physiol. Renal Physiol. 262 1992 F591 F599
40. I. Pombo Gregoire, A.M. Correia, and M.P. Soares Tu-P7: 62 heme oxygenase-1 derived carbon monoxide inhibits atherosclerosis Atheroscler 7 3 2006 198
41. J. Cao, K. Inoue, X. Li, G. Drummond, and N.G. Abraham Physiological significance of heme oxygenase in hypertension Int. J. Biochem.Cell Biol. 41 2009 1025 1033
42. S.W. Ryter, H.P. Kim, K. Nakahira, B.S. Zuckerbraun, D. Morse, and A.M. Choi Protective functions of heme oxygenase-1 and carbon monoxide in the respiratory system Antioxid. Redox Signal. 9 2007 2157 2173 (Pubitemid 350059027)
43. T. Takahashi, H. Shimizu, H. Morimatsu, K. Inoue, R. Akagi, K. Morita, and S. Sassa Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation Mini Rev. Med. Chem. 7 2007 745 753 (Pubitemid 47099174)
44. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820 (Pubitemid 34000785)
45. M. He, R.C.M. Siow, D. Sugden, L. Gao, X. Cheng, and G.E. Mann Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes Nutr. Metab. Cardiovasc. Dis. 21 2011 277 285
46. G. Renie, F. Maingrette, and L. Li Diabetic vasculopathy and the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) Curr. Diabetes Rev. 3 2007 103 110 (Pubitemid 46773850)
47. I.A. Leclercq, A. Da Silva Morais, B. Schroyen, N. Van Hul, and A. Geerts Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences J. Hepatol. 47 2007 142 156 (Pubitemid 46830723)
48. T. Miyata, and T. Dan Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy? Diabetes Res. Clin. Pract. 82 Suppl. 1 2008 S25 S29
49. A. Bierhaus, M.A. Hofmann, R. Ziegler, and P.P. Nawroth AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovasc. Res. 37 1998 586 600 (Pubitemid 28231153)
50. K.M. Kim, Y.S. Kim, D.H. Jung, J. Lee, and J.S. Kim Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose Exp. Cell Res. 318 2012 152 159
51. H. Vlassara Advanced glycation in diabetic renal and vascular disease Kidney Int. Suppl. 51 1995 S43 S44
52. R.C.Y. Lin, C.G. Schyvens, Y. Zhang, J.A. Whitworth, and B.J. Morris Tumor necrosis factor receptor 2 mRNA in rat models of hypertension Am. J. Hypertens. 16 2003 685 688 (Pubitemid 36900593)
53. K. Yamagata, A. Miyashita, M. Chino, and H. Matsufuji Apigenin inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells Microvasc. Res. 81 2011 60 67
54. H.Y. Chang, and X. Yang Proteases for cell suicide: functions and regulation of caspases Microbiol. Mol. Biol. Rev. 64 2000 821 846 (Pubitemid 32475932)
55. P.J. Barnes Nuclear factor-kappa B Int. J. Biochem. Cell Biol. 29 1997 867 870
56. M. Karin, Z. Liu, and E. Zandi AP-1 function and regulation Curr. Opin. Cell Biol. 9 1997 240 246 (Pubitemid 27135992)
57. S. Ghosh, M.J. May, and E.B. Kopp NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260 (Pubitemid 28183365)
58. H.M. El-Bassossy, M.A. El-Moselhy, and M.F. Mahmoud Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition Naunyn Schmiedebergs Arch. Pharmacol. 384 2011 277 285
59. J.B. Giardina, G.M. Green, K.L. Cockrell, J.P. Granger, and R.A. Khalil TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2002 R130 R143
60. F.J. Alarcon-Aguilar, A. Fortis-Barrera, S. Angeles-Mejia, T.R. Banderas-Dorantes, E.I. Jasso-Villagomez, J.C. Almanza-Perez, G. Blancas-Flores, A. Zamilpa, M. Diaz-Flores, and R. Roman-Ramos Anti-inflammatory and antioxidant effects of a hypoglycemic fructan fraction from Psacalium peltatum (H.B.K.) Cass. in streptozotocin-induced diabetes mice J. Ethnopharmacol. 132 2010 400 407
61. E. Fadillioglu, E. Oztas, H. Erdogan, M. Yagmurca, S. Sogut, M. Ucar, and M.K. Irmak Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats J. Appl. Toxicol. 24 2004 47 52 (Pubitemid 38181541)
62. S.H. Abduljawad, M.F. El-Refaei, and N.N. El-Nashar Protective and anti-angiopathy effects of caffeic acid phenethyl ester against induced type 1 diabetes in vivo Int. Immunopharmacol. 17 2013 408 414
63. C. Gebhard, B.E. Stahli, S. Largiader, E.W. Holy, A. Akhmedov, G.G. Camici, T.F. Lscher, and F.C. Tanne Caffeic acid phenethyl ester inhibits endothelial tissue factor expression Biol. Pharm. Bull. 36 2013 1032 1035
64. J.O. Mapesa, N. Waldschmitt, I. Schmoeller, C. Blume, T. Hofmann, S. Mahungu, T. Clavel, and D. Haller Catechols in caffeic acid phenethyl ester are essential for inhibition of TNF-mediated IP-10 expression through NF-κB-dependent but HO-1- and p38-independent mechanisms in mouse intestinal epithelial cells Mol. Nutr. Food Res. 55 2011 1850 1861
65. A.J. Bailey, R.G. Paul, and L. Knott Mechanisms of maturation and ageing of collagen Mech. Ageing Dev. 106 1998 1 56 (Pubitemid 28559274)
66. J.E. Bishop Regulation of cardiovascular collagen deposition by mechanical forces Mol. Med. Today 4 1998 69 75 (Pubitemid 28139144)
67. O. Chappey, C. Dosquet, M.P. Wautier, and J.L. Wautier Advanced glycation end products, oxidant stress and vascular lesions Eur. J. Clin. Invest. 27 1997 97 108 (Pubitemid 27101380)
68. M.J. Barnes, and R.W. Farndale Collagens and atherosclerosis Exp. Gerontol. 34 1999 513 525 (Pubitemid 29383870)
69. R. Kesava AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats Microvasc. Res. 68 2004 132 142 (Pubitemid 39093887)
70. M.D. Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc. Res. 41 1999 376 384 (Pubitemid 29087334)
71. J. Marin Age-related changes in vascular responses: a review Mech. Ageing Dev. 79 1995 71 114
72. U. Koltuksuz, H.M. Mutuscedi, R. Kutlu, H. Zyurt, S. Etin, A. Karaman, N. Guumlrbuumlz, O.M. Akyol, and N.E. Aydiotan Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats J. Pediatr. Surg. 36 2001 1504 1509 (Pubitemid 32927656)
73. R.A. DeFronzo, and E. Ferrannini Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194